1. Wang, Tao, Liu, Yufeng, Li, Qing, Liu, Dawei, Li, Bin. 2022. Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. In Frontiers in immunology, 13, 999823. doi:10.3389/fimmu.2022.999823. https://pubmed.ncbi.nlm.nih.gov/36225932/
2. Xu, Jiahao, Hu, Zhengang, Cao, Hui, Cheng, Quan, Li, Jingbo. 2022. Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma. In Frontiers in immunology, 13, 981764. doi:10.3389/fimmu.2022.981764. https://pubmed.ncbi.nlm.nih.gov/36605188/
3. Lu, Hanwen, Zhou, Liwei, Zhang, Bingchang, Yang, Huiyin, Wang, Zhanxiang. 2022. Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma. In Frontiers in medicine, 9, 939776. doi:10.3389/fmed.2022.939776. https://pubmed.ncbi.nlm.nih.gov/36523779/
4. Sun, Bo, Ding, Peng, Song, Yinghui, Peng, Chuang, Liu, Sulai. 2024. FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. In Redox biology, 75, 103302. doi:10.1016/j.redox.2024.103302. https://pubmed.ncbi.nlm.nih.gov/39128228/
5. Wang, Chao, Guo, Jingjing, Zhang, Yun, Zhou, Shusheng, Jiang, Bing. 2024. Cuproptosis-Related Gene FDX1 Suppresses the Growth and Progression of Colorectal Cancer by Retarding EMT Progress. In Biochemical genetics, , . doi:10.1007/s10528-024-10784-8. https://pubmed.ncbi.nlm.nih.gov/38520567/
智鼠故事 
